Novo, Ascendis to work on monthly GLP-1; KalVista makes a royalty deal

Plus, news about Disc Medicine, OSE Immunotherapeutics, CrossBridge Bio, Lomond Therapeutics, Relief Therapeutics and Renexxion:

Novo Nordisk, Ascendis Pharma ink deal: The Danish drugmaker …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Which GLP-1 Drug Was Tied to a Signal of Suicidal Thoughts?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

August 25, 2024

Getting ahead of a non-alcoholic beverage boom among youths

The non-alcoholic beverage market is booming right now: zero-proof bottle shops and bars are popping up across the country; a non-alcoholic beer brand is even

June 20, 2024

J&J to close its Leiden vaccine unit following wider infectious disease cuts

Johnson & Johnson’s Janssen plans to close down its vaccine and infectious disease unit in Leiden, the Netherlands, according to local news outlets. The Leiden

August 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.